SNY Stock Latest News

Recursion Pharmaceuticals Stock (RXRX) Soars 15% on a $10M Milestone Payment from Sanofi

PremiumMarket News

2d ago

Sanofi, pCPA sign letter of intent for Dupixent across four indications

RXRX

PremiumThe Fly

2d ago

Midday Fly By: Anthropic reports revenue ahead of IPO, TSMC reports Q3 beat

PremiumThe Fly

2d ago

PremiumThe Fly

Recursion announces Sanofi option for development candidate

2d ago

RXRX

PremiumCompany AnnouncementsSanofi’s RSV Study in Queensland Offers Fresh Clues on Nirsevimab Uptake

3d ago

EU accepts Sanofi’s concessions to end probe over vaccine marketing

The Fly

EU accepts Sanofi’s concessions to end probe over vaccine marketing

3d ago

Regeneron price target raised to $930 from $870 at Jefferies

The Fly

Regeneron price target raised to $930 from $870 at Jefferies

16d ago

Expanded Sanofi agreement particularly favorable for Regeneron, says TD Cowen

PremiumThe Fly

16d ago

Regeneron, Sanofi expand long-standing antibody collaboration

PremiumThe Fly

16d ago

Sanofi’s Teplizumab Study Signals a New Front in Pediatric Type 1 Diabetes

PremiumCompany Announcements

18d ago

Sanofi’s Chinese Pediatric Meningococcal Vaccine Trial Advances, Sharpening Long-Term Growth Prospects for SNY

PremiumCompany Announcements

25d ago

PremiumThe FlyTrump Trade: U.S. announces deal with Denmark over Greenland’s security

26d ago

AZN

BMY

Sanofi Targets Teen Acne With New mRNA Vaccine Trial, Opening a Fresh Growth Avenue for SNY

Company Announcements

Sanofi Targets Teen Acne With New mRNA Vaccine Trial, Opening a Fresh Growth Avenue for SNY

29d ago

U.S. weighs allowing most pharma licensing deals with China, Reuters says

Sanofi Strikes Strategic Deal With Cheplapharm to Hand Over 20 Mature Medicines and Three Plants

The Fly

U.S. weighs allowing most pharma licensing deals with China, Reuters says

29d ago

AZN

BMY

PremiumCompany Announcements

30d ago

Sanofi Targets Senior Respiratory Risk With New Phase 2b RSV+HMPV Vaccine Trial

PremiumCompany Announcements

1M ago

Sanofi inaugurates Canadian flu vaccine faclity

PremiumThe Fly

1M ago

Sanofi, Cheplapharm enter strategic partnership

PremiumThe Fly

1M ago

PremiumThe FlySanofi price target raised to EUR 100 from EUR 95 at HSBC

1M ago

Sanofi initiated with a Sector Perform at RBC Capital

The Fly

Sanofi initiated with a Sector Perform at RBC Capital

1M ago

Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials

Market News

Novartis Stock (NVS) Pops as Multiple Sclerosis Drug Shows Positive Results in Late-Stage Trials

2M ago

NVS